Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Instagram Outage Disrupts Thousands of U.S. Users 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
BETHLEHEM, Pa., May 08, 2017 -- B. Braun Medical Inc. will introduce the single-use Actreen® Mini Catheter and the Actreen® Mini Set at the American Urological Association (AUA) annual conference in Boston. The small, lightweight Actreen Mini Catheter is designed for women who have urine retention or a voiding dysfunction and need an intermittent catheter.
The pre-lubricated catheter has a no-touch design for access to the catheter, eliminating the need for insertion supplies. The catheter’s hydrophilic lubricant is designed to keep the catheter lubricated, which makes water activation unnecessary. The product’s low-profile packaging includes a discreet pouch for carrying a daily supply of catheters. The pre-lubricated catheter is not made with natural rubber latex, DEHP or PVC.
“The packaging and small size of the Actreen Mini makes it a great option for women who have active lifestyles,” said Jeff Straton, Director of Chronic Care for B. Braun. “The Actreen Mini is a B. Braun catheter that has been successfully used since 2010 by women in Europe, and we are pleased to now offer this product in the North American market.”
The Actreen Mini Set includes a catheter, a 700 ml bag with a graduated scale and an anti-reflux valve to avoid leaks during and after catheterization.
AUA attendees can learn more about the Actreen Mini Catheter and Actreen Mini Set at booth #848 at the conference from May 13-15 at the Boston Convention Center in Massachusetts.
About B. Braun
B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the health care industry. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, Pa., and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap® and CAPS®.
Globally, the B. Braun Group of Companies employs more than 58,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, visit www.BBraunUSA.com.
Contact: Jason Ford B. Braun Medical Inc. 610.997.4722 [email protected]
